The most reasonable number of Finerenone tablets 10mg per day and dosage instructions

Finerenone is a new type of non-steroidal selective mineral cortical receptor antagonist. It is mainly used in patients with chronic kidney disease and type 2 diabetes to reduce the risk of renal progression and the incidence of cardiovascular events. Its mechanism of action is to reduce renal inflammation and fibrosis by inhibiting the mineralocorticoid receptor (MR), thereby delaying the decline of renal function. Correct dosing is critical for efficacy and safety.

Based on clinical trials and drug labeling, the common starting dose of fenelidone is 10 mg orally once daily. For patients with good renal function, 10 mg can be used directly or the dose can be adjusted appropriately based on serum potassium level and renal function assessment. Tablets should be taken at a fixed time every day, with or without food, but keeping them at the same time every day will help stabilize the blood concentration and ensure efficacy.

Dose adjustment is mainly based on serum potassium levels and renal function (eGFR). Serum potassium monitoring is usually required within 4 weeks during initial treatment and after dose adjustment. If the serum potassium rises above 5.5 mmol/L, the doctor may temporarily stop the drug or reduce the dose; if the renal function declines significantly (eGFR<30 mL/min/1.73m²), it is necessary to evaluate whether to continue use or adjust the dose. Individualized dose adjustment can maximize the renal and cardiovascular protective effects of fenelin while reducing the risk of hyperkalemia.

In general, for most patients with chronic kidney disease and type 2 diabetes, one tablet of 10 mg per day is a reasonable starting dose. During the medication, it is necessary to strictly follow the doctor's recommendations to monitor blood potassium and kidney function regularly, and adjust the dose based on the results. Through scientific management, fenelidone can effectively slow down the progression of kidney disease while taking into account safety and provide patients with long-term treatment options.

Reference link:https://www.drugs.com